1. Lifetime Risk of Developing or Dying from Cancer Basic Facts.  American Cancer Society, 2019.

2. Wamberg Genomic Advisors, Cancer Survey of 204 cancer patients and nonprofessional advocates.  Survey Sampling International (SSI), 2018.

3. Unger, Joseph M., et al. Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical and Physician and Patient Barriers to Cancer Clinical Trial Participation.  JNCI J NATL Cancer Institute, 2019.

4. Family Reach. Annual Report 2016. Family Reach Foundation https://familyreachorg/wp-content/uploads/2017/05/ frf_2016_annual_report_compressedpdf Accessed July 30, 2017.

5. CancerCare. Cancer Care Patient Access and Engagement Report. New York: CancerCare. 2016.

6. NIH Website

7. Waszak, Przemyslaw M. et al.  The Spread of Medical Fake News in Social Media.  Health Policy & Technology Review, Elsevier, 2018.

8. Manchanda, Ranjit, et al.  Population based germline testing for primary cancer prevention.  Oncotarget, 2018, Vol. 9 (No. 69), pp: 33062-33063

9. Stephen S. Raab M.D. et al. “Clinical Impact and Frequency of Anatomic pathology Errors in Cancer Diagnosis

10. Edward Maldonado, Scott Parsons, Emerson Yu-sheng Chen, Alyson Haslam, and Vinay Prasad Estimation of U.S. patients with cancer who may respond to cytotoxic chemotherapy. Journal of Clinical Oncology 2019 37:15_suppl, e18228-e18228

11. The State of Cancer Care in America, 2014: A report by the American Society of Clinical Oncology.  Journal of Oncology Practice, 2014; 10(2):120-122

12. Sun Life Stop-Loss Report, 2019.


14. Measuring Health-Related Productivity Loss.


16.  Wamberg Genomic Advisors Cancer Survey of 204 cancer patients and nonprofessional advocates fielded by Survey Sampling International (SSI), 2018.  Available at: